A House Republican has filed a bill that says health-care providers could not “discriminate” against patients based on ...

The new bill, called the "Health Care Medical Freedom Act," would, in part, prohibit Florida providers from refusing to see ...

Lifordi Immunotherapeutics and other biotechnology companies are using antibodies to precisely target drugs in the body.

Learn more about whether Agilent Technologies, Inc. or Charles River Laboratories International, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key ...

Learn more about whether Charles River Laboratories International, Inc. or Danaher Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial ...

Clinical data presented at ASCO 2025 showed an objective response rate (ORR) of 63% among all patients, with a median progression-free survival (PFS) of 7.7 months. Responses were seen across ...

Explore Pfizer Inc.’s 2025-2026 outlook: challenges, flat revenues, patent risks, and potential from the Metsera deal. Click ...

Adding another potential wrinkle to the industry’s work with China is the Biosecure Act, a piece of China-targeting national ...

Very few people get to invent a new language that is heard by millions: DW talked to linguist Paul Frommer about how he ...

Seers Technology, D&D Pharmatech, OliX, ABL Bio. Among the top 10 stocks with the highest stock price increases this year, ...

Innovation is accelerating through bispecifics and dual payload strategies | Emerging ADC development approaches such as bispecific antibodies and dual-payloads are opening new avenues to address ...

Pfizer is pursuing pipeline expansions through the Metsera acquisition and a major licensing deal with 3SBio. Find out why ...